Resveratrol nanodispersion with high stability and dissolution rate

LWT

Volumn 50, Issue 2, 2013, Pages 622-628

  Zhang, Xiao Ping ^a   Le, Yuan ^a   Wang, Jie Xin ^a   Zhao, Hong ^a   Chen, Jian Feng ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Antioxidant activity; Dissolution; Nanodispersion; Resveratrol; Stability

Indexed keywords

ANTIOXIDANTS; CONVERGENCE OF NUMERICAL METHODS; DISSOLUTION; SOLUBILITY; STABILITY;

ACTIVE INGREDIENTS; ANTI-OXIDANT ACTIVITIES; ANTI-SOLVENT PRECIPITATIONS; AQUEOUS SOLUBILITY; LIPOPHILIC MATERIALS; NANO-DISPERSIONS; PHYSIOLOGICAL ACTIVITY; WATER SOLUBILITIES;

RESVERATROL;

EID: 84867843130     PISSN: 00236438     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lwt.2012.07.041     Document Type: Article

References (30)

1. Athar M., Back J.H., Tang X.W., Kim K.H., Kopelovich L., Bickers D.R., et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicology and Applied Pharmacology 2007, 224:274-283.
2. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery 2006, 5:493-506.
3. Bertelli A.A.E., Giovannini L., Stradi R., Urien S., Tillement J.P., Bertelli A. Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats. International Journal of Clinical Pharmacology Research 1996, 16:77-81.
4. Caruso F., Tanski J., Estrada A.V., Rossi M. Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. Journal of Agricultural and Food Chemistry 2004, 52:7279-7285.
5. Casper R.F., Quesne M., Rogers I.M., Shirota T., Jolivet A., Milgrom E., et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Molecular Pharmacology 1999, 56:784-790.
6. Dani C., Bonatto D., Salvador M., Pereira M.D., Henriques J.P., Eleutherio E. Antioxidant protection of resveratrol and catechin in saccharomyces cerevisiae. Journal of Agricultural and Food Chemistry 2008, 56:4268-4272.
7. Date A.A., Patravale V.B. Current strategies for engineering drug nanoparticles. Current Opinion in Colloid & Interface Science 2004, 9:222-235.
8. Delmas D., Passilly-Degrace P., Jannin B., Mustapha C.M., Latruffe N. Latruffe, resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. International Journal of Molecular Medicine 2002, 10:193-199.
9. Dinunzio J.C., Miller D.A., Yang W., Mcginity G.W., Williams R.O. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Molecular Pharmacology 2008, 5:968-980.
10. Elaine M.L., Liversidge G.G., Cooper E.R., Merisko E., Liversidge G.G., Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. European Journal of Pharmaceutical Sciences 2003, 18:113-120.
11. Fan E., Zhang L., Jiang S., Bai Y. Beneficial effects of resveratrol on atherosclerosis. Journal of Medicinal Food 2008, 11:610-614.
12. Gresele P., Cerletti C., Guglielmini G., Pignatelli P., Gaetano G.D., Violi F. Effects of resveratrol and other wine polyphenols on vascular function: an update. Journal of Nutritional Biochemistry 2011, 22:201-211.
13. Halls C., Yu O. Potential for metabolic engineering of resveratrol biosynthesis. Trends in Biotechnology 2007, 26:77-81.
14. Horn D., Rieger J. Organic nanoparticles in the aqueous phase-theory, experiment, and use. Angewandte Chemie-International Edition 2001, 40:4330.
15. Kim S.Y., Kim J.H., Kim S.K. Antioxidant activities of selected oriental herb extracts. Journal of the American Oil Chemists Society 1994, 71:633-640.
16. López-Nicolás J.M., Núñez-Delicado E., Pérez-López A.J., Barrachina A.C., Cuadra-Crespo P. Determination of stoichiometric coefficients and apparent formation constants for β-cyclodextrin complexes of trans-resveratrol using reversed-phase liquid chromatography. Journal of Chromatography A 2006, 1135:158-165.
17. Lu Z., Cheng B., Hu Y., Zhang Y., Zou G.Z. Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity. Food Chemistry 2009, 113:17-20.
18. Milner J.A., McDonald S.S., Anderson D.E., Greenwald P. Molecular, targets for nutrients involved with cancer prevention. Nutrition and Cancer 2001, 41:1-16.
19. Murua A., Portero A., Orive G., Hernández R.M., Castro M., Pedraz J.L. Cell microencapsulation technology: towards clinical application. Journal of Controlled Release 2008, 132:76-83.
20. Nam J.B., Ryu J.H., Kim J.W., Chang I.S., Suh K.D. Stabilization of resveratrol immobilized in monodisperse cyano-functionalized porous polymeric microspheres. Polymer 2005, 46:8956-8963.
21. Raghavan S.L., Trividic A., Davis A.F., Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. International Journal of Pharmaceutics 2001, 212:213.
22. Ruan B.F., Lu X., Tang J.F., Wei Y., Wang X.L., Zhang Y.B., et al. Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents. Bioorganic & Medicinal Chemistry Letters 2011, 19:2688-2695.
23. Sanganwar G.P., Gupta R.B. Enhancement of shelf life and handling properties of drug nanoparticles: nanoscale mixing of itraconazole with silica. Industrial & Engineering Chemistry Research 2008, 47:4717-4725.
24. Shi G., Rao L., Yu H., Xiang H., Yang H., Ji R. Stabilization and encapsulation of photosensitive resveratrol within yeast cell. International Journal of Pharmaceutics 2008, 349:83-93.
25. Sobolev V.S., Cole R.J. Trans-resveratrol content in commercial peanuts and peanut products. Journal of Agricultural and Food Chemistry 1999, 47:1435-1439.
26. Swanepoel E., Liebenberg W., de Villiers M.M., Dekker T.G. Dissolution properties of proxicam powders and capsules as a function of particle size and the agglomeration of powders. Drug Development and Industrial Pharmacy 2000, 26:1067-1076.
27. Terayama H., Inada K., Nakayama H., Yasueda S., Esumi K. Preparation of stable aqueous suspension of a hydrophobic drug with polymers. Colloids and Surfaces B-Biointerfaces 2004, 39:159.
28. Trela B.C., Waterhouse A.L. Resveratrol: isomeric molar absorptivities and stability. Journal of Agricultural and Food Chemistry 1996, 44:1253-1257.
29. Tzeng C.W., Yen F.L., Wu T.H., Ko H.H., Lee C.W., Tzeng W.S., et al. Enhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering process. Journal of Agricultural and Food Chemistry 2011, 59:5073-5080.
30. Zhang Z.B., Shen Z.G., Wang J.X., Zhao H., Chen J.F., Yun J. Nanonization of megestrol acetate by liquid precipitation. Industrial & Engineering Chemistry Research 2009, 48:8493-8499.